scispace - formally typeset
M

Mark A. Valasek

Researcher at University of California, San Diego

Publications -  111
Citations -  8083

Mark A. Valasek is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Fatty liver. The author has an hindex of 36, co-authored 98 publications receiving 6141 citations. Previous affiliations of Mark A. Valasek include University of Texas Southwestern Medical Center & University of Washington Medical Center.

Papers
More filters
Journal ArticleDOI

Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41

TL;DR: C2-C6 short-chain fatty acids, ligands of an orphan G protein-coupled receptor GPR41, stimulate leptin expression in both a mouse adipocyte cell line and mouse adipose tissue in primary culture, suggesting the relevance of this pathway in vivo.
Journal ArticleDOI

The power of real-time PCR.

TL;DR: The basic concepts, chemistries, and instrumentation of real-time PCR are discussed and the present applications and future perspectives for this technology in biomedical sciences and in life science education are included.
Journal ArticleDOI

Review article: the global emergence of Helicobacter pylori antibiotic resistance.

TL;DR: This study highlights the importance of knowing the carrier and removal status of canine coronavirus, as a source of infection for other animals, not necessarily belonging to the same breeds.
Journal ArticleDOI

Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients with Biopsy-proven Nonalcoholic Fatty Liver Disease

TL;DR: In a prospective, cross-sectional study of more than 100 patients, MRE is found to be more accurate than TE in identification of liver fibrosis (stage 1 or more), using biopsy analysis as the standard and MRI-PDFF is more accurate in detecting all grades of steatosis in patients with NAFLD.